Abstract
Numerous phosphocalcium alterations associated with bone mineral density in hypertension have been described, but very few studies assess them. This study assesses bone mass in hypertensive postmenopausal women and the hypertension influence determining both calcium homeostasis and bone turnover markers. Blood and urine samples were analysed for calcium metabolism-related parameters. Densitometry studies were conducted in the lumbar spine (L2–L4). Hypertensive osteoporotic women—selected from 82 women, with 22% osteoporosis prevalence, similar to the rate for the same age in the Spanish population—had significantly higher levels of body mass index (29±4 vs 26±4, P=0.019), calciuria (293±146 vs 210±116 mg/24 h, P=0.023) and calcium/creatinine ratio (0.33±0.2 vs 0.22±0.1 P=0.003) vs hypertensive nonosteoporotic women. No relation was found between systolic and diastolic blood pressure with bone mass. However, there was a negative osteocalcin correlation (r=−0.386, P=0.0001, and r=−0.242, P=0.033). Calciuria is associated with bone mass decrease in hypertensive women, and there is no relation between bone mass and blood pressure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McCarron DA et al. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinarycalcium leak. Hypertension 1980; 2: 162–168.
Young EV, Morris CD, McCarron DA . Urinary calcium excretion in essential hypertension. J Lab Clin Med 1992; 120: 624–632.
Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A . Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J 1988; 296: 814–816.
Brickman AS et al. Calcitropic hormones, platelet calcium and blood pressure in essential hypertension. Hypertension 1990; 16: 512–522.
McCarron DA . Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med 1982; 307: 226–228.
Gadallah M et al. Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function. Am J Hypertens 1991; 4: 404–409.
Wang TM, Hsu JF, Jee WSS, Matthews JL . Evidence for reduced cancellous bone mass in the spontaneously hypertensive rats. Bone Mineral 1993; 20: 251–264.
Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA . High blood pressure and bone mineral loss in elderly white women: a prospective study. Lancet 1999; 354: 971–975.
Delmas PD, Eastell R, Garnero P et al. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int 2000; 6: S2–S17.
Diaz Curiel M et al. Prevalencia de osteoporosis por densitometría en la población femenina española. Med Clin Barcelona 2001; 116: 86–88.
Tsuda K, Nistui I, Masuyama Y . Bone: mineral density in women with essential hypertension. Am J Hypertens 2001; 14: 704–707.
Cappuccio FP, Kalaitzidis R, Duneclift S, Eastwood JB . Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J Nephrol 2000; 13: 169–177.
Cruz DN et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37: 1458–1464.
Cruz DM . The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density? Nephrol Dial Transplant 2001; 16: 691–694.
Borry EL et al. Expression of the sodium-chloride cotransporter in osteoblast-like cells: effects of thiazide diuretics. Am J Physiol 1997; 272: C109–C116.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pérez-Castrillón, J., Justo, I., Silva, J. et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens 17, 107–110 (2003). https://doi.org/10.1038/sj.jhh.1001520
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001520
Keywords
This article is cited by
-
Linking metabolic syndrome with low bone mass through insights from BMI and health behaviors
Scientific Reports (2023)
-
Effect of Primary Hypertension on Treatment Outcomes of Patients with Postmenopausal Osteoporosis: A 5 Year Follow Up Retrospective Study
High Blood Pressure & Cardiovascular Prevention (2019)
-
Do metabolic syndrome and its components have an impact on bone mineral density in adolescents?
Nutrition & Metabolism (2017)
-
Hypertension, Antihypertensive Drugs, and Bone Mineral Density
Clinical Reviews in Bone and Mineral Metabolism (2015)
-
Osteocalcin attenuates high fat diet-induced impairment of endothelium-dependent relaxation through Akt/eNOS-dependent pathway
Cardiovascular Diabetology (2014)